Shiro Mita
Founder at M's Science Corp.
Shiro Mita active positions
| Companies | Position | Start | End |
|---|---|---|---|
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Director/Board Member | 31/10/2000 | - |
| Founder | 31/10/2000 | - |
Career history of Shiro Mita
Former positions of Shiro Mita
| Companies | Position | Start | End |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 29/02/2016 | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Director/Board Member | - | - |
| ACUCELA INC | Director/Board Member | 30/04/2015 | - |
| Keio University | Corporate Officer/Principal | - | - |
Training of Shiro Mita
| University of Tokyo | Doctorate Degree |
Statistics
International
| Japan | 6 |
| United States | 2 |
Operational
| Director/Board Member | 4 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Shiro Mita
- Experience
